Loading...

TEM TEMPUS AI INC Company Mergers 8-K Filing

TMPS

TM

TEMPUS AI INC

(TEM)

2024 8-K

Financial Results Release

Financial Results Update

Financial Results Update

Financial Results Announced

Stock Registration Filing

Financial Statements

Debt Restructuring

Financial Statements

Financial Results

Credit Agreement Update

Financial Results

Acquisition Announcement

Financial Results

Stock Unit Deferral

External Links:

Tempus AI Inc. has agreed to buy Ambry Genetics for $375 million in cash and 4.84 million shares of its stock, with the deal expected to close in early 2025, pending regulatory approvals.

AI Assistant

TEMPUS AI INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.